The global prevalence of diabetes continues to rise, with projections indicating a substantial increase in disease burden over the coming decades ( Patients with T2DM and ESRD represent a particularly high-risk population characterized by advanced metabolic dysfunction, a high burden of cardiovascular disease, and extensive polypharmacy ( Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) improve glycemic control by increasing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and inducing weight loss
Analysis of Factors Affecting Successful Clinical Trial Enrollment in the Context of Three Prospective, Randomized, Controlled Trials
We know that maintaining cognitive health is crucial
Nature Reviews
The contents of the cecum were mixed with sterilized water at a rate of 0.25 g per 1 ml and centrifuged at 13,000 g for 15 min, and then 100 l of supernatant was used
Protocol 2: tirzepatide microdose for autoimmune inflammation Goal: Leverage dual GIP/GLP-1 receptor activation for broader anti-inflammatory coverage Starting dose: 0.5 mg tirzepatide subcutaneously, once weekly Week 1 to 6: Hold at 0.5 mg
